The Medical Research Future Fund (MRFF) Emerging Priorities and Consumer Driven Research (EPCDR) Initiative aims to enable or support:
- High quality biomedical, clinical, health services and/or population health research which improves patient care
- Translation of new discoveries into clinical practice
- New diagnoses, treatments and cures to those suffering from rare and debilitating conditions
- Joint collaboration of consumers and researchers in undertaking research in emerging priority areas, and
- Many Australians with debilitating conditions
The objectives of the 2019 Ovarian Cancer Research grant opportunity aims to:
- Facilitate innovative, high quality research which will lead to:
- Improved diagnosis and treatment of ovarian cancer
- Research which will address the gaps in research, leading to a better understanding of the causes and underlying factors which contribute to the development and progression of ovarian cancer
- Facilitate consumer involvement in the design and evaluation of the research project (including participation in the conduct of the research)
- Provide high-quality evidence for the new health treatments and/or drugs (where appropriate)
- Enable rapid translation of consumer-relevant research into clinical practice, health policy and/or health advice which will lead to positive impacts for consumers
- Encourage the development of multi-disciplinary research teams which deliver measurable outcomes which are a priority for consumers
- Encourage collaboration between research teams, policy makers, healthcare funders and the health delivery sector (e.g. education, community, industry and/or healthcare)
The total amount available is $20 million. Applications must be submitted electronically via the Research Grants Management System (RGMS).
Applications close 2pm (AWST), Wednesday 5 February, 2020. More information